APO Research
Talk to an analyst

APO RESEARCH · REPORT

Spermicides

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Spermicides Market Outlook and Growth Opportunities 2026

30 December 2025190 pages

Choose your research edition.

Industry ResearchSpermicides Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Spermicides Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Spermicides Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Spermicides Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Spermicides Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Spermicides market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Spermicides is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Spermicides is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Spermicides is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Spermicides market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Spermicides market include Advantage-S, Conceptrol, Crinone, Delfen Foam, Emko, Encare, Endometrin, First-Progesterone VGS and Gynol II, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Spermicides market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Spermicides and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Spermicides sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Spermicides market size, projected growth trends, production technologies, key applications, and end-use industries.

Spermicides Segment by Company

Advantage-S

Conceptrol

Crinone

Delfen Foam

Emko

Encare

Endometrin

First-Progesterone VGS

Gynol II

Phexxi

Prochieve

Spermicides Segment by Type

Suppositories

Creams

Foams

Gels

Film

Spermicides Segment by Application

Online Pharmacies

Retail Pharmacies

Hospital

Spermicides Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Spermicides status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Spermicides market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Spermicides significant trends, drivers, influence factors in global and regions.

6. To analyze Spermicides competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Spermicides market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Spermicides and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Spermicides.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Spermicides market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Spermicides industry.

Chapter 3: Detailed analysis of Spermicides manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Spermicides in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Spermicides in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Spermicides Industry Trends Table 2. Spermicides Industry Drivers Table 3. Spermicides Industry Opportunities and Challenges Table 4. Spermicides Industry Restraints Table 5. Global Spermicides Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Spermicides Revenue Share by Company (2021-2026) Table 7. Global Spermicides Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Spermicides Sales Volume Share by Company (2021-2026) Table 9. Global Spermicides Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Spermicides Company Ranking, (2024-2026) & (USD Million) Table 11. Global Spermicides Key Company Manufacturing Base & Headquarters Table 12. Global Spermicides Company, Product Type & Application Table 13. Global Spermicides Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Spermicides by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Suppositories Table 18. Significant Companies of Creams Table 19. Significant Companies of Foams Table 20. Significant Companies of Gels Table 21. Significant Companies of Film Table 22. Global Spermicides Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 23. Global Spermicides Sales Volume by Type (2021-2026) & (K Units) Table 24. Global Spermicides Sales Volume by Type (2027-2032) & (K Units) Table 25. Global Spermicides Sales Volume Share by Type (2021-2026) Table 26. Global Spermicides Sales Volume Share by Type (2027-2032) Table 27. Global Spermicides Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Spermicides Sales Value by Type (2021-2026) & (US$ Million) Table 29. Global Spermicides Sales Value by Type (2027-2032) & (US$ Million) Table 30. Global Spermicides Sales Value Share by Type (2021-2026) Table 31. Global Spermicides Sales Value Share by Type (2027-2032) Table 32. Significant Companies of Online Pharmacies Table 33. Significant Companies of Retail Pharmacies Table 34. Significant Companies of Hospital Table 35. Global Spermicides Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 36. Global Spermicides Sales Volume by Application (2021-2026) & (K Units) Table 37. Global Spermicides Sales Volume by Application (2027-2032) & (K Units) Table 38. Global Spermicides Sales Volume Share by Application (2021-2026) Table 39. Global Spermicides Sales Volume Share by Application (2027-2032) Table 40. Global Spermicides Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 41. Global Spermicides Sales Value by Application (2021-2026) & (US$ Million) Table 42. Global Spermicides Sales Value by Application (2027-2032) & (US$ Million) Table 43. Global Spermicides Sales Value Share by Application (2021-2026) Table 44. Global Spermicides Sales Value Share by Application (2027-2032) Table 45. Global Spermicides Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 46. Global Spermicides Sales by Region (2021-2026) & (K Units) Table 47. Global Spermicides Sales Market Share by Region (2021-2026) Table 48. Global Spermicides Sales by Region (2027-2032) & (K Units) Table 49. Global Spermicides Sales Market Share by Region (2027-2032) Table 50. Global Spermicides Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 51. Global Spermicides Sales Value by Region (2021-2026) & (US$ Million) Table 52. Global Spermicides Sales Value Share by Region (2021-2026) Table 53. Global Spermicides Sales Value by Region (2027-2032) & (US$ Million) Table 54. Global Spermicides Sales Value Share by Region (2027-2032) Table 55. Global Spermicides Market Average Price (US$/Unit) by Region (2021-2026) Table 56. Global Spermicides Market Average Price (US$/Unit) by Region (2027-2032) Table 57. Global Spermicides Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 58. Global Spermicides Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Spermicides Sales by Country (2021-2026) & (K Units) Table 60. Global Spermicides Sales Market Share by Country (2021-2026) Table 61. Global Spermicides Sales by Country (2027-2032) & (K Units) Table 62. Global Spermicides Sales Market Share by Country (2027-2032) Table 63. Global Spermicides Sales Value by Country (2021-2026) & (US$ Million) Table 64. Global Spermicides Sales Value Market Share by Country (2021-2026) Table 65. Global Spermicides Sales Value by Country (2027-2032) & (US$ Million) Table 66. Global Spermicides Sales Value Market Share by Country (2027-2032) Table 67. Advantage-S Company Information Table 68. Advantage-S Business Overview Table 69. Advantage-S Spermicides Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 70. Advantage-S Spermicides Product Portfolio Table 71. Advantage-S Recent Development Table 72. Conceptrol Company Information Table 73. Conceptrol Business Overview Table 74. Conceptrol Spermicides Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Conceptrol Spermicides Product Portfolio Table 76. Conceptrol Recent Development Table 77. Crinone Company Information Table 78. Crinone Business Overview Table 79. Crinone Spermicides Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Crinone Spermicides Product Portfolio Table 81. Crinone Recent Development Table 82. Delfen Foam Company Information Table 83. Delfen Foam Business Overview Table 84. Delfen Foam Spermicides Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Delfen Foam Spermicides Product Portfolio Table 86. Delfen Foam Recent Development Table 87. Emko Company Information Table 88. Emko Business Overview Table 89. Emko Spermicides Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Emko Spermicides Product Portfolio Table 91. Emko Recent Development Table 92. Encare Company Information Table 93. Encare Business Overview Table 94. Encare Spermicides Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Encare Spermicides Product Portfolio Table 96. Encare Recent Development Table 97. Endometrin Company Information Table 98. Endometrin Business Overview Table 99. Endometrin Spermicides Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Endometrin Spermicides Product Portfolio Table 101. Endometrin Recent Development Table 102. First-Progesterone VGS Company Information Table 103. First-Progesterone VGS Business Overview Table 104. First-Progesterone VGS Spermicides Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. First-Progesterone VGS Spermicides Product Portfolio Table 106. First-Progesterone VGS Recent Development Table 107. Gynol II Company Information Table 108. Gynol II Business Overview Table 109. Gynol II Spermicides Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. Gynol II Spermicides Product Portfolio Table 111. Gynol II Recent Development Table 112. Phexxi Company Information Table 113. Phexxi Business Overview Table 114. Phexxi Spermicides Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 115. Phexxi Spermicides Product Portfolio Table 116. Phexxi Recent Development Table 117. Prochieve Company Information Table 118. Prochieve Business Overview Table 119. Prochieve Spermicides Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 120. Prochieve Spermicides Product Portfolio Table 121. Prochieve Recent Development Table 122. Key Raw Materials Table 123. Raw Materials Key Suppliers Table 124. Spermicides Distributors List Table 125. Spermicides Customers List Table 126. Research Programs/Design for This Report Table 127. Authors List of This Report Table 128. Secondary Sources Table 129. Primary Sources List of Figures Figure 1. Spermicides Product Image Figure 2. Global Spermicides Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Spermicides Sales Value (2021-2032) & (US$ Million) Figure 4. Global Spermicides Sales (2021-2032) & (K Units) Figure 5. Global Spermicides Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Spermicides Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Suppositories Image Figure 10. Creams Image Figure 11. Foams Image Figure 12. Gels Image Figure 13. Film Image Figure 14. Global Spermicides Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 15. Global Spermicides Sales Volume Share 2021 VS 2025 VS 2032 Figure 16. Global Spermicides Sales Volume Share by Type (2021-2032) Figure 17. Global Spermicides Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Spermicides Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global Spermicides Sales Value Share by Type (2021-2032) Figure 20. Online Pharmacies Image Figure 21. Retail Pharmacies Image Figure 22. Hospital Image Figure 23. Global Spermicides Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 24. Global Spermicides Sales Volume Share 2021 VS 2025 VS 2032 Figure 25. Global Spermicides Sales Volume Share by Application (2021-2032) Figure 26. Global Spermicides Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Spermicides Sales Value Share 2021 VS 2025 VS 2032 Figure 28. Global Spermicides Sales Value Share by Application (2021-2032) Figure 29. Global Spermicides Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 30. Global Spermicides Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 31. Global Spermicides Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 32. Global Spermicides Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 33. North America Spermicides Sales Value (2021-2032) & (US$ Million) Figure 34. North America Spermicides Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Europe Spermicides Sales Value (2021-2032) & (US$ Million) Figure 36. Europe Spermicides Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Asia-Pacific Spermicides Sales Value (2021-2032) & (US$ Million) Figure 38. Asia-Pacific Spermicides Sales Value Share by Country (%), 2025 VS 2032 Figure 39. South America Spermicides Sales Value (2021-2032) & (US$ Million) Figure 40. South America Spermicides Sales Value Share by Country (%), 2025 VS 2032 Figure 41. Middle East & Africa Spermicides Sales Value (2021-2032) & (US$ Million) Figure 42. Middle East & Africa Spermicides Sales Value Share by Country (%), 2025 VS 2032 Figure 43. USA Spermicides Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. USA Spermicides Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. USA Spermicides Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Canada Spermicides Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Canada Spermicides Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Canada Spermicides Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Mexico Spermicides Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Mexico Spermicides Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Mexico Spermicides Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Germany Spermicides Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Germany Spermicides Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Germany Spermicides Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. France Spermicides Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. France Spermicides Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. France Spermicides Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. U.K. Spermicides Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. U.K. Spermicides Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. U.K. Spermicides Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Italy Spermicides Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Italy Spermicides Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Italy Spermicides Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Spain Spermicides Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Spain Spermicides Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Spain Spermicides Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Russia Spermicides Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Russia Spermicides Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Russia Spermicides Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Netherlands Spermicides Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Netherlands Spermicides Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Netherlands Spermicides Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. Nordic Countries Spermicides Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. Nordic Countries Spermicides Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. Nordic Countries Spermicides Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. China Spermicides Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. China Spermicides Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. China Spermicides Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Japan Spermicides Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Japan Spermicides Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Japan Spermicides Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. South Korea Spermicides Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. South Korea Spermicides Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. South Korea Spermicides Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. India Spermicides Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. India Spermicides Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. India Spermicides Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Australia Spermicides Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Australia Spermicides Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Australia Spermicides Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Southeast Asia Spermicides Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Southeast Asia Spermicides Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Southeast Asia Spermicides Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Brazil Spermicides Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Brazil Spermicides Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Brazil Spermicides Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Argentina Spermicides Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Argentina Spermicides Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Argentina Spermicides Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Chile Spermicides Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Chile Spermicides Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Chile Spermicides Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Colombia Spermicides Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Colombia Spermicides Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Colombia Spermicides Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Peru Spermicides Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Peru Spermicides Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Peru Spermicides Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Spermicides Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Saudi Arabia Spermicides Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Saudi Arabia Spermicides Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Israel Spermicides Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Israel Arabia Spermicides Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Israel Arabia Spermicides Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. UAE Spermicides Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. UAE Spermicides Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. UAE Spermicides Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Turkey Spermicides Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Turkey Spermicides Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Turkey Spermicides Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Iran Spermicides Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Iran Spermicides Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Iran Spermicides Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Egypt Spermicides Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 125. Egypt Spermicides Sales Value Share by Type, 2025 VS 2032 & (%) Figure 126. Egypt Spermicides Sales Value Share by Application, 2025 VS 2032 & (%) Figure 127. Spermicides Value Chain Figure 128. Manufacturing Cost Structure Figure 129. Spermicides Sales Mode & Process Figure 130. Direct Comparison with Distribution Share Figure 131. Distributors Profiles Figure 132. Years Considered Figure 133. Research Process Figure 134. Key Executives Interviewed

Scope & coverage.

Types
  • Suppositories
  • Creams
  • Foams
  • Gels
  • Film
Applications
  • Online Pharmacies
  • Retail Pharmacies
  • Hospital
Companies covered
  • Advantage-S
  • Conceptrol
  • Crinone
  • Delfen Foam
  • Emko
  • Encare
  • Endometrin
  • First-Progesterone VGS
  • Gynol II
  • Phexxi
  • Prochieve

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Spermicides Sales Value (2021-2032)
  4. 1.2.2 Global Spermicides Sales Volume (2021-2032)
  5. 1.2.3 Global Spermicides Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Spermicides Market Dynamics
  1. 2.1 Spermicides Industry Trends
  2. 2.2 Spermicides Industry Drivers
  3. 2.3 Spermicides Industry Opportunities and Challenges
  4. 2.4 Spermicides Industry Restraints
3 Spermicides Market by Company
  1. 3.1 Global Spermicides Company Revenue Ranking in 2025
  2. 3.2 Global Spermicides Revenue by Company (2021-2026)
  3. 3.3 Global Spermicides Sales Volume by Company (2021-2026)
  4. 3.4 Global Spermicides Average Price by Company (2021-2026)
  5. 3.5 Global Spermicides Company Ranking (2024-2026)
  6. 3.6 Global Spermicides Company Manufacturing Base and Headquarters
  7. 3.7 Global Spermicides Company Product Type and Application
  8. 3.8 Global Spermicides Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Spermicides Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Spermicides Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Spermicides Market by Type
  1. 4.1 Spermicides Type Introduction
  2. 4.1.1 Suppositories
  3. 4.1.2 Creams
  4. 4.1.3 Foams
  5. 4.1.4 Gels
  6. 4.1.5 Film
  7. 4.2 Global Spermicides Sales Volume by Type
  8. 4.2.1 Global Spermicides Sales Volume by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Spermicides Sales Volume by Type (2021-2032)
  10. 4.2.3 Global Spermicides Sales Volume Share by Type (2021-2032)
  11. 4.3 Global Spermicides Sales Value by Type
  12. 4.3.1 Global Spermicides Sales Value by Type (2021 VS 2025 VS 2032)
  13. 4.3.2 Global Spermicides Sales Value by Type (2021-2032)
  14. 4.3.3 Global Spermicides Sales Value Share by Type (2021-2032)
5 Spermicides Market by Application
  1. 5.1 Spermicides Application Introduction
  2. 5.1.1 Online Pharmacies
  3. 5.1.2 Retail Pharmacies
  4. 5.1.3 Hospital
  5. 5.2 Global Spermicides Sales Volume by Application
  6. 5.2.1 Global Spermicides Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Spermicides Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Spermicides Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Spermicides Sales Value by Application
  10. 5.3.1 Global Spermicides Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Spermicides Sales Value by Application (2021-2032)
  12. 5.3.3 Global Spermicides Sales Value Share by Application (2021-2032)
6 Spermicides Regional Sales and Value Analysis
  1. 6.1 Global Spermicides Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Spermicides Sales by Region (2021-2032)
  3. 6.2.1 Global Spermicides Sales by Region: 2021-2026
  4. 6.2.2 Global Spermicides Sales by Region (2027-2032)
  5. 6.3 Global Spermicides Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Spermicides Sales Value by Region (2021-2032)
  7. 6.4.1 Global Spermicides Sales Value by Region: 2021-2026
  8. 6.4.2 Global Spermicides Sales Value by Region (2027-2032)
  9. 6.5 Global Spermicides Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Spermicides Sales Value (2021-2032)
  12. 6.6.2 North America Spermicides Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Spermicides Sales Value (2021-2032)
  15. 6.7.2 Europe Spermicides Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Spermicides Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Spermicides Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Spermicides Sales Value (2021-2032)
  21. 6.9.2 South America Spermicides Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Spermicides Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Spermicides Sales Value Share by Country, 2025 VS 2032
7 Spermicides Country-level Sales and Value Analysis
  1. 7.1 Global Spermicides Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Spermicides Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Spermicides Sales by Country (2021-2032)
  4. 7.3.1 Global Spermicides Sales by Country (2021-2026)
  5. 7.3.2 Global Spermicides Sales by Country (2027-2032)
  6. 7.4 Global Spermicides Sales Value by Country (2021-2032)
  7. 7.4.1 Global Spermicides Sales Value by Country (2021-2026)
  8. 7.4.2 Global Spermicides Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Spermicides Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Spermicides Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Spermicides Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Spermicides Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Spermicides Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Spermicides Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Spermicides Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Spermicides Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Spermicides Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Spermicides Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Spermicides Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Spermicides Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Spermicides Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Spermicides Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Spermicides Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Spermicides Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Spermicides Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Spermicides Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Spermicides Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Spermicides Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Spermicides Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Spermicides Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Spermicides Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Spermicides Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Spermicides Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Spermicides Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Spermicides Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Spermicides Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Spermicides Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Spermicides Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Spermicides Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Spermicides Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Spermicides Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Spermicides Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Spermicides Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Spermicides Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Spermicides Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Spermicides Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Spermicides Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Spermicides Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Spermicides Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Spermicides Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Spermicides Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Spermicides Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Spermicides Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Spermicides Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Spermicides Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Spermicides Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Spermicides Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Spermicides Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Spermicides Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Spermicides Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Spermicides Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Spermicides Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Spermicides Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Spermicides Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Spermicides Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Spermicides Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Spermicides Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Spermicides Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Spermicides Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Spermicides Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Spermicides Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Spermicides Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Spermicides Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Spermicides Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Spermicides Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Spermicides Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Spermicides Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Spermicides Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Spermicides Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Spermicides Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Spermicides Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Spermicides Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Spermicides Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Spermicides Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Spermicides Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Spermicides Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Spermicides Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Spermicides Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Spermicides Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Spermicides Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Spermicides Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Spermicides Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Advantage-S
  2. 8.1.1 Advantage-S Company Information
  3. 8.1.2 Advantage-S Business Overview
  4. 8.1.3 Advantage-S Spermicides Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Advantage-S Spermicides Product Portfolio
  6. 8.1.5 Advantage-S Recent Developments
  7. 8.2 Conceptrol
  8. 8.2.1 Conceptrol Company Information
  9. 8.2.2 Conceptrol Business Overview
  10. 8.2.3 Conceptrol Spermicides Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Conceptrol Spermicides Product Portfolio
  12. 8.2.5 Conceptrol Recent Developments
  13. 8.3 Crinone
  14. 8.3.1 Crinone Company Information
  15. 8.3.2 Crinone Business Overview
  16. 8.3.3 Crinone Spermicides Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Crinone Spermicides Product Portfolio
  18. 8.3.5 Crinone Recent Developments
  19. 8.4 Delfen Foam
  20. 8.4.1 Delfen Foam Company Information
  21. 8.4.2 Delfen Foam Business Overview
  22. 8.4.3 Delfen Foam Spermicides Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Delfen Foam Spermicides Product Portfolio
  24. 8.4.5 Delfen Foam Recent Developments
  25. 8.5 Emko
  26. 8.5.1 Emko Company Information
  27. 8.5.2 Emko Business Overview
  28. 8.5.3 Emko Spermicides Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Emko Spermicides Product Portfolio
  30. 8.5.5 Emko Recent Developments
  31. 8.6 Encare
  32. 8.6.1 Encare Company Information
  33. 8.6.2 Encare Business Overview
  34. 8.6.3 Encare Spermicides Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Encare Spermicides Product Portfolio
  36. 8.6.5 Encare Recent Developments
  37. 8.7 Endometrin
  38. 8.7.1 Endometrin Company Information
  39. 8.7.2 Endometrin Business Overview
  40. 8.7.3 Endometrin Spermicides Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Endometrin Spermicides Product Portfolio
  42. 8.7.5 Endometrin Recent Developments
  43. 8.8 First-Progesterone VGS
  44. 8.8.1 First-Progesterone VGS Company Information
  45. 8.8.2 First-Progesterone VGS Business Overview
  46. 8.8.3 First-Progesterone VGS Spermicides Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 First-Progesterone VGS Spermicides Product Portfolio
  48. 8.8.5 First-Progesterone VGS Recent Developments
  49. 8.9 Gynol II
  50. 8.9.1 Gynol II Company Information
  51. 8.9.2 Gynol II Business Overview
  52. 8.9.3 Gynol II Spermicides Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Gynol II Spermicides Product Portfolio
  54. 8.9.5 Gynol II Recent Developments
  55. 8.10 Phexxi
  56. 8.10.1 Phexxi Company Information
  57. 8.10.2 Phexxi Business Overview
  58. 8.10.3 Phexxi Spermicides Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Phexxi Spermicides Product Portfolio
  60. 8.10.5 Phexxi Recent Developments
  61. 8.11 Prochieve
  62. 8.11.1 Prochieve Company Information
  63. 8.11.2 Prochieve Business Overview
  64. 8.11.3 Prochieve Spermicides Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Prochieve Spermicides Product Portfolio
  66. 8.11.5 Prochieve Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Spermicides Value Chain Analysis
  2. 9.1.1 Spermicides Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Spermicides Sales Mode & Process
  6. 9.2 Spermicides Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Spermicides Distributors
  9. 9.2.3 Spermicides Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst